Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors

Clinical trial NCT05040360 · RECRUITING

Trial details

NCT number: NCT05040360
Sponsor: SWOG Cancer Research Network
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Malignant Neoplasm in the Liver Pancreatic Neuroendocrine Tumor Stage I Pancreatic Neuroendocrine Tumor AJCC v8 Stage II Pancreatic Neuroendocrine Tumor AJCC v8 Stage III Pancreatic Neuroendocrine Tumor AJCC v8

Start date: 2022-05-05
Primary completion: 2027-03-31
Enrollment: 141

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.